Year |
Citation |
Score |
2022 |
Lenoir S, Lahaye RA, Vitet H, Scaramuzzino C, Virlogeux A, Capellano L, Genoux A, Gershoni-Emek N, Geva M, Hayden MR, Saudou F. Pridopidine rescues BDNF/TrkB trafficking dynamics and synapse homeostasis in a Huntington disease brain-on-a-chip model. Neurobiology of Disease. 105857. PMID 36075537 DOI: 10.1016/j.nbd.2022.105857 |
0.305 |
|
2021 |
Virlogeux A, Scaramuzzino C, Lenoir S, Carpentier R, Louessard M, Genoux A, Lino P, Hinckelmann MV, Perrier AL, Humbert S, Saudou F. Increasing brain palmitoylation rescues behavior and neuropathology in Huntington disease mice. Science Advances. 7. PMID 33789888 DOI: 10.1126/sciadv.abb0799 |
0.305 |
|
2020 |
Agasse F, Mendez-David I, Christaller W, Carpentier R, Braz BY, David DJ, Saudou F, Humbert S. Chronic Corticosterone Elevation Suppresses Adult Hippocampal Neurogenesis by Hyperphosphorylating Huntingtin. Cell Reports. 32: 107865. PMID 32640230 DOI: 10.1016/J.Celrep.2020.107865 |
0.382 |
|
2020 |
Bruyère J, Abada YS, Vitet HM, Fontaine G, Deloulme JC, Cès A, Denarier E, Pernet-Gallay K, Andrieux A, Humbert S, Potier MC, Delatour B, Saudou F. Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of Huntingtin. Elife. 9. PMID 32452382 DOI: 10.7554/Elife.56371 |
0.32 |
|
2020 |
Asselin L, Rivera Alvarez J, Heide S, Bonnet CS, Tilly P, Vitet H, Weber C, Bacino CA, Baranaño K, Chassevent A, Dameron A, Faivre L, Hanchard NA, Mahida S, McWalter K, ... ... Saudou F, et al. Mutations in the KIF21B kinesin gene cause neurodevelopmental disorders through imbalanced canonical motor activity. Nature Communications. 11: 2441. PMID 32415109 DOI: 10.1038/S41467-020-16294-6 |
0.355 |
|
2020 |
Vitet H, Brandt V, Saudou F. Traffic signaling: new functions of huntingtin and axonal transport in neurological disease. Current Opinion in Neurobiology. 63: 122-130. PMID 32408142 DOI: 10.1016/J.Conb.2020.04.001 |
0.382 |
|
2020 |
Ehinger Y, Bruyère J, Panayotis N, Abada YS, Borloz E, Matagne V, Scaramuzzino C, Vitet H, Delatour B, Saidi L, Villard L, Saudou F, Roux JC. Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice. Embo Molecular Medicine. e10889. PMID 31913581 DOI: 10.15252/Emmm.201910889 |
0.391 |
|
2019 |
Kacher R, Lamazière A, Heck N, Kappes V, Mounier C, Despres G, Dembitskaya Y, Perrin E, Christaller W, Sasidharan Nair S, Messent V, Cartier N, Vanhoutte P, Venance L, Saudou F, et al. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease. Brain : a Journal of Neurology. PMID 31286142 DOI: 10.1093/Brain/Awz174 |
0.408 |
|
2018 |
Zhang H, Zhang C, Vincent J, Zala D, Benstaali C, Sainlos M, Grillo-Bosch D, Daburon S, Coussen F, Cho Y, David DJ, Saudou F, Humeau Y, Choquet D. Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in Huntington's disease models. Nature Communications. 9: 4272. PMID 30323233 DOI: 10.1038/S41467-018-06675-3 |
0.33 |
|
2018 |
Galvan L, Francelle L, Gaillard MC, de Longprez L, Carrillo-de Sauvage MA, Liot G, Cambon K, Stimmer L, Luccantoni S, Flament J, Valette J, de Chaldée M, Auregan G, Guillermier M, Joséphine C, ... ... Saudou F, et al. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain : a Journal of Neurology. PMID 29534157 DOI: 10.1093/Brain/Awy057 |
0.42 |
|
2018 |
Virlogeux A, Moutaux E, Christaller W, Genoux A, Bruyère J, Fino E, Charlot B, Cazorla M, Saudou F. Reconstituting Corticostriatal Network on-a-Chip Reveals the Contribution of the Presynaptic Compartment to Huntington's Disease. Cell Reports. 22: 110-122. PMID 29298414 DOI: 10.1016/J.Celrep.2017.12.013 |
0.328 |
|
2018 |
Kacher R, Kappes V, Lamazière A, Heck N, Despres G, Dembitskaia L, Perrin E, Christaller W, Nair SS, Messent V, Venance L, Saudou F, Néri C, Vanhoutte P, Caboche J, et al. I13 Striatal regulation of cholesterol metabolism by CYP46A1 is associated with multiple benefits in huntington’s disease knock-in mice models Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.249 |
0.394 |
|
2018 |
Migazzi A, Tripathy D, Scaramuzzino C, Pandey UB, Saudou F, Pennuto M, Basso M. A14 Arginine methylation of huntingtin is a novel post-translational modification that impacts huntington’s disease pathogenesis Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.14 |
0.376 |
|
2017 |
Khrimian L, Obri A, Ramos-Brossier M, Rousseaud A, Moriceau S, Nicot AS, Mera P, Kosmidis S, Karnavas T, Saudou F, Gao XB, Oury F, Kandel E, Karsenty G. Gpr158 mediates osteocalcin's regulation of cognition. The Journal of Experimental Medicine. PMID 28851741 DOI: 10.1084/Jem.20171320 |
0.343 |
|
2016 |
Kratter IH, Zahed H, Lau A, Tsvetkov AS, Daub AC, Weiberth KF, Gu X, Saudou F, Humbert S, Yang XW, Osmand A, Steffan JS, Masliah E, Finkbeiner S. Serine 421 regulates mutant huntingtin toxicity and clearance in mice. The Journal of Clinical Investigation. PMID 27525439 DOI: 10.1172/Jci80339 |
0.406 |
|
2016 |
Saudou F, Humbert S. The Biology of Huntingtin. Neuron. 89: 910-26. PMID 26938440 DOI: 10.1016/J.Neuron.2016.02.003 |
0.375 |
|
2016 |
Virlogeux A, Cazorla M, Bruyère J, Christaller W, Genoux A, Charlot B, Saudou F. B41 HD on chip : reconstituting the cortico-striatal network on microfluidics to study intracellular trafficking and synaptic transmission Journal of Neurology, Neurosurgery & Psychiatry. 87: A23.3-A24. DOI: 10.1136/Jnnp-2016-314597.72 |
0.302 |
|
2015 |
El-Daher MT, Hangen E, Bruyère J, Poizat G, Al-Ramahi I, Pardo R, Bourg N, Souquere S, Mayet C, Pierron G, Lévêque-Fort S, Botas J, Humbert S, Saudou F. Huntingtin proteolysis releases non-polyQ fragments that cause toxicity through dynamin 1 dysregulation. The Embo Journal. 34: 2255-71. PMID 26165689 DOI: 10.15252/Embj.201490808 |
0.356 |
|
2015 |
Naia L, Ferreira IL, Cunha-Oliveira T, Duarte AI, Ribeiro M, Rosenstock TR, Laço MN, Ribeiro MJ, Oliveira CR, Saudou F, Humbert S, Rego AC. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts. Molecular Neurobiology. 51: 331-48. PMID 24841383 DOI: 10.1007/S12035-014-8735-4 |
0.309 |
|
2014 |
Marquer C, Laine J, Dauphinot L, Hanbouch L, Lemercier-Neuillet C, Pierrot N, Bossers K, Le M, Corlier F, Benstaali C, Saudou F, Thinakaran G, Cartier N, Octave JN, Duyckaerts C, et al. Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Molecular Neurodegeneration. 9: 60. PMID 25524049 DOI: 10.1186/1750-1326-9-60 |
0.313 |
|
2014 |
Ochaba J, Lukacsovich T, Csikos G, Zheng S, Margulis J, Salazar L, Mao K, Lau AL, Yeung SY, Humbert S, Saudou F, Klionsky DJ, Finkbeiner S, Zeitlin SO, Marsh JL, et al. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proceedings of the National Academy of Sciences of the United States of America. 111: 16889-94. PMID 25385587 DOI: 10.1073/Pnas.1420103111 |
0.377 |
|
2014 |
Drouet V, Ruiz M, Zala D, Feyeux M, Auregan G, Cambon K, Troquier L, Carpentier J, Aubert S, Merienne N, Bourgois-Rocha F, Hassig R, Rey M, Dufour N, Saudou F, et al. Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells. Plos One. 9: e99341. PMID 24926995 DOI: 10.1371/Journal.Pone.0099341 |
0.366 |
|
2014 |
Lopes C, Ribeiro M, Duarte AI, Humbert S, Saudou F, Pereira de Almeida L, Hayden M, Rego AC. IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice. Molecular Neurobiology. 49: 1126-42. PMID 24347322 DOI: 10.1007/S12035-013-8585-5 |
0.397 |
|
2013 |
Hinckelmann MV, Zala D, Saudou F. Releasing the brake: restoring fast axonal transport in neurodegenerative disorders. Trends in Cell Biology. 23: 634-43. PMID 24091156 DOI: 10.1016/J.Tcb.2013.08.007 |
0.335 |
|
2013 |
Pla P, Orvoen S, Benstaali C, Dodier S, Gardier AM, David DJ, Humbert S, Saudou F. Huntingtin acts non cell-autonomously on hippocampal neurogenesis and controls anxiety-related behaviors in adult mouse. Plos One. 8: e73902. PMID 24019939 DOI: 10.1371/Journal.Pone.0073902 |
0.399 |
|
2013 |
Liot G, Zala D, Pla P, Mottet G, Piel M, Saudou F. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 6298-309. PMID 23575829 DOI: 10.1523/Jneurosci.2033-12.2013 |
0.379 |
|
2013 |
Zala D, Hinckelmann MV, Saudou F. Huntingtin's function in axonal transport is conserved in Drosophila melanogaster. Plos One. 8: e60162. PMID 23555909 DOI: 10.1371/Journal.Pone.0060162 |
0.362 |
|
2013 |
Saudou F, Zala D, Pla P, Hinckelmann M, Liot G. S.04.03 BDNF/TrkB signaling, axonal and dendritic transport and neurodegeneration in Huntington's disease European Neuropsychopharmacology. 23: S116. DOI: 10.1016/S0924-977X(13)70136-6 |
0.3 |
|
2012 |
Saudou F. A "so cilia" network: cilia proteins start "social" networking. The Journal of Clinical Investigation. 122: 1198-202. PMID 22446182 DOI: 10.1172/Jci62971 |
0.305 |
|
2012 |
Orvoen S, Pla P, Gardier AM, Saudou F, David DJ. Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation. Neuroscience Letters. 507: 127-32. PMID 22178857 DOI: 10.1016/J.Neulet.2011.11.063 |
0.355 |
|
2012 |
Roux JC, Zala D, Panayotis N, Borges-Correia A, Saudou F, Villard L. Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway. Neurobiology of Disease. 45: 786-95. PMID 22127389 DOI: 10.1016/J.Nbd.2011.11.002 |
0.368 |
|
2012 |
Ben M'Barek K, Orvoen S, Pla P, Benstaali C, Godin J, Gardier A, Saudou F, David D, Humbert S. B14 Huntingtin mediates anxiety/depression-related behaviours in mouse through BDNF transport and hippocampal neurogenesis Journal of Neurology, Neurosurgery & Psychiatry. 83: A10.1-A10. DOI: 10.1136/Jnnp-2012-303524.30 |
0.307 |
|
2012 |
Zala D, Hinckelmann V, Liot G, Pla P, Humbert S, Saudou F. B13 axonal transport, energy supply and huntingtin Journal of Neurology, Neurosurgery, and Psychiatry. 83. DOI: 10.1136/Jnnp-2012-303524.29 |
0.303 |
|
2011 |
Keryer G, Pineda JR, Liot G, Kim J, Dietrich P, Benstaali C, Smith K, Cordelières FP, Spassky N, Ferrante RJ, Dragatsis I, Saudou F. Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. The Journal of Clinical Investigation. 121: 4372-82. PMID 21985783 DOI: 10.1172/Jci57552 |
0.691 |
|
2010 |
Godin JD, Colombo K, Molina-Calavita M, Keryer G, Zala D, Charrin BC, Dietrich P, Volvert ML, Guillemot F, Dragatsis I, Bellaiche Y, Saudou F, Nguyen L, Humbert S. Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron. 67: 392-406. PMID 20696378 DOI: 10.1016/J.Neuron.2010.06.027 |
0.384 |
|
2010 |
del Toro D, Xifró X, Pol A, Humbert S, Saudou F, Canals JM, Alberch J. Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease. Journal of Neurochemistry. 115: 153-67. PMID 20663016 DOI: 10.1111/J.1471-4159.2010.06912.X |
0.683 |
|
2010 |
Pardo R, Molina-Calavita M, Poizat G, Keryer G, Humbert S, Saudou F. pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking. Molecular Brain. 3: 17. PMID 20515468 DOI: 10.1186/1756-6606-3-17 |
0.346 |
|
2010 |
Twelvetrees AE, Yuen EY, Arancibia-Carcamo IL, MacAskill AF, Rostaing P, Lumb MJ, Humbert S, Triller A, Saudou F, Yan Z, Kittler JT. Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron. 65: 53-65. PMID 20152113 DOI: 10.1016/J.Neuron.2009.12.007 |
0.302 |
|
2010 |
Nguyen L, Humbert S, Saudou F, Chariot A. Elongator - an emerging role in neurological disorders. Trends in Molecular Medicine. 16: 1-6. PMID 20036197 DOI: 10.1016/J.Molmed.2009.11.002 |
0.351 |
|
2009 |
Pineda JR, Pardo R, Zala D, Yu H, Humbert S, Saudou F. Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease. Molecular Brain. 2: 33. PMID 19860865 DOI: 10.1186/1756-6606-2-33 |
0.682 |
|
2008 |
Zala D, Colin E, Rangone H, Liot G, Humbert S, Saudou F. Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Human Molecular Genetics. 17: 3837-46. PMID 18772195 DOI: 10.1093/Hmg/Ddn281 |
0.393 |
|
2008 |
Saudou F, Humbert S. The biology of Huntington's disease. Handbook of Clinical Neurology. 89: 619-29. PMID 18631783 DOI: 10.1016/S0072-9752(07)01257-2 |
0.419 |
|
2008 |
Colin E, Zala D, Liot G, Rangone H, Borrell-Pagès M, Li XJ, Saudou F, Humbert S. Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. The Embo Journal. 27: 2124-34. PMID 18615096 DOI: 10.1038/Emboj.2008.133 |
0.348 |
|
2008 |
Roze E, Saudou F, Caboche J. Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Current Opinion in Neurology. 21: 497-503. PMID 18607213 DOI: 10.1097/Wco.0B013E328304B692 |
0.312 |
|
2007 |
Anne SL, Saudou F, Humbert S. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7318-28. PMID 17611284 DOI: 10.1523/Jneurosci.1831-07.2007 |
0.342 |
|
2007 |
Dompierre JP, Godin JD, Charrin BC, Cordelières FP, King SJ, Humbert S, Saudou F. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3571-83. PMID 17392473 DOI: 10.1523/Jneurosci.0037-07.2007 |
0.359 |
|
2006 |
Borrell-Pagès M, Zala D, Humbert S, Saudou F. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cellular and Molecular Life Sciences : Cmls. 63: 2642-60. PMID 17041811 DOI: 10.1007/S00018-006-6242-0 |
0.418 |
|
2006 |
Humbert S, Saudou F. The ataxia-ome: connecting disease proteins of the cerebellum. Cell. 125: 645-7. PMID 16713557 DOI: 10.1016/J.Cell.2006.05.007 |
0.321 |
|
2006 |
Borrell-Pagès M, Canals JM, Cordelières FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, Cheetham ME, Néri C, Alberch J, Brouillet E, Saudou F, et al. Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. The Journal of Clinical Investigation. 116: 1410-24. PMID 16604191 DOI: 10.1172/Jci27607 |
0.758 |
|
2006 |
Pardo R, Colin E, Régulier E, Aebischer P, Déglon N, Humbert S, Saudou F. Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 1635-45. PMID 16452687 DOI: 10.1523/Jneurosci.3706-05.2006 |
0.373 |
|
2006 |
Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P, Déglon N, Brouillet E. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Molecular Biology of the Cell. 17: 1652-63. PMID 16452635 DOI: 10.1091/Mbc.E05-07-0607 |
0.332 |
|
2005 |
Humbert S, Saudou F. [Huntington's disease: intracellular signaling pathways and neuronal death]. Journal De La SociéTé De Biologie. 199: 247-51. PMID 16471265 DOI: 10.1051/Jbio:2005026 |
0.451 |
|
2005 |
Colin E, Régulier E, Perrin V, Dürr A, Brice A, Aebischer P, Déglon N, Humbert S, Saudou F. Akt is altered in an animal model of Huntington's disease and in patients. The European Journal of Neuroscience. 21: 1478-88. PMID 15845076 DOI: 10.1111/J.1460-9568.2005.03985.X |
0.391 |
|
2005 |
Rangone H, Pardo R, Colin E, Girault JA, Saudou F, Humbert S. Phosphorylation of arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced toxicity by rescuing proteasome impairment. The Journal of Biological Chemistry. 280: 22021-8. PMID 15809304 DOI: 10.1074/Jbc.M407528200 |
0.374 |
|
2004 |
Rangone H, Humbert S, Saudou F. Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic? Pathologie-Biologie. 52: 338-42. PMID 15261377 DOI: 10.1016/J.Patbio.2003.06.004 |
0.396 |
|
2004 |
Gauthier LR, Charrin BC, Borrell-Pagès M, Dompierre JP, Rangone H, Cordelières FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell. 118: 127-38. PMID 15242649 DOI: 10.1016/J.Cell.2004.06.018 |
0.396 |
|
2004 |
Rangone H, Poizat G, Troncoso J, Ross CA, MacDonald ME, Saudou F, Humbert S. The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. The European Journal of Neuroscience. 19: 273-9. PMID 14725621 DOI: 10.1111/J.0953-816X.2003.03131.X |
0.374 |
|
2003 |
Holbert S, Dedeoglu A, Humbert S, Saudou F, Ferrante RJ, Néri C. Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America. 100: 2712-7. PMID 12604778 DOI: 10.1073/Pnas.0437967100 |
0.403 |
|
2003 |
Humbert S, Saudou F. Huntingtin phosphorylation and signaling pathways that regulate toxicity in Huntington's disease Clinical Neuroscience Research. 3: 149-155. DOI: 10.1016/S1566-2772(03)00057-4 |
0.385 |
|
2002 |
Humbert S, Bryson EA, Cordelières FP, Connors NC, Datta SR, Finkbeiner S, Greenberg ME, Saudou F. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Developmental Cell. 2: 831-7. PMID 12062094 DOI: 10.1016/S1534-5807(02)00188-0 |
0.669 |
|
2002 |
Humbert S, Saudou F. Toward cell specificity in SCA1. Neuron. 34: 669-70. PMID 12062012 DOI: 10.1016/S0896-6273(02)00715-8 |
0.382 |
|
1998 |
Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95: 55-66. PMID 9778247 DOI: 10.1016/S0092-8674(00)81782-1 |
0.53 |
|
1998 |
Hiroi N, Marek GJ, Brown JR, Ye H, Saudou F, Vaidya VA, Duman RS, Greenberg ME, Nestler EJ. Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 6952-62. PMID 9712664 DOI: 10.1523/Jneurosci.18-17-06952.1998 |
0.537 |
|
1998 |
Brown JR, Nigh E, Lee RJ, Ye H, Thompson MA, Saudou F, Pestell RG, Greenberg ME. Fos family members induce cell cycle entry by activating cyclin D1. Molecular and Cellular Biology. 18: 5609-19. PMID 9710644 DOI: 10.1128/Mcb.18.9.5609 |
0.726 |
|
1998 |
Lucas JJ, Yamamoto A, Scearce-Levie K, Saudou F, Hen R. Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 5537-44. PMID 9651234 DOI: 10.1523/Jneurosci.18-14-05537.1998 |
0.726 |
|
1998 |
Hiroi N, Marek GJ, Brown JR, Ye H, Saudou F, Vaidya VA, Duman RS, Greenberg ME, Nestler EJ. Essential Role of thefosB Gene in Molecular, Cellular, and Behavioral Actions of Chronic Electroconvulsive Seizures The Journal of Neuroscience. 18: 6952-6962. DOI: 10.1523/JNEUROSCI.18-17-06952.1998 |
0.365 |
|
1997 |
Gourfinkel-An I, Cancel G, Trottier Y, Devys D, Tora L, Lutz Y, Imbert G, Saudou F, Stevanin G, Agid Y, Brice A, Mandel JL, Hirsch EC. Differential distribution of the normal and mutated forms of huntingtin in the human brain. Annals of Neurology. 42: 712-9. PMID 9392570 DOI: 10.1002/Ana.410420507 |
0.566 |
|
1997 |
David G, Abbas N, Stevanin G, Dürr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genetics. 17: 65-70. PMID 9288099 DOI: 10.1038/Ng0997-65 |
0.545 |
|
1997 |
Cancel G, Dürr A, Didierjean O, Imbert G, Bürk K, Lezin A, Belal S, Benomar A, Abada-Bendib M, Vial C, Guimarães J, Chneiweiss H, Stevanin G, Yvert G, Abbas N, ... Saudou F, et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Human Molecular Genetics. 6: 709-15. PMID 9158145 DOI: 10.1093/Hmg/6.5.709 |
0.535 |
|
1997 |
David G, Abbas N, Stevanin G, Durr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, et al. Cloning of the gene for autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7) reveals a highly unstable CAG repeat expansion Neuromuscular Disorders. 7: 467. DOI: 10.1016/S0960-8966(97)87325-7 |
0.526 |
|
1996 |
Saudou F, Devys D, Trottier Y, Imbert G, Stoeckel ME, Brice A, Mandel JL. Polyglutamine expansions and neurodegenerative diseases. Cold Spring Harbor Symposia On Quantitative Biology. 61: 639-47. PMID 9246490 DOI: 10.1101/Sqb.1996.061.01.064 |
0.544 |
|
1996 |
Stevanin G, Trottier Y, Cancel G, Dürr A, David G, Didierjean O, Bürk K, Imbert G, Saudou F, Abada-Bendib M, Gourfinkel-An I, Benomar A, Abbas N, Klockgether T, Grid D, et al. Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias. Human Molecular Genetics. 5: 1887-92. PMID 8968739 DOI: 10.1093/Hmg/5.12.1887 |
0.562 |
|
1996 |
Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM, Weber C, Mandel JL, Cancel G, Abbas N, Dürr A, Didierjean O, Stevanin G, Agid Y, Brice A. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genetics. 14: 285-91. PMID 8896557 DOI: 10.1038/Ng1196-285 |
0.557 |
|
1996 |
Ramboz S, Saudou F, Amara DA, Belzung C, Segu L, Misslin R, Buhot MC, Hen R. 5-HT1B receptor knock out--behavioral consequences. Behavioural Brain Research. 73: 305-12. PMID 8788525 DOI: 10.1016/0166-4328(96)00119-2 |
0.523 |
|
1996 |
Ramboz S, Saudou F, Amara DA, Belzung C, Dierich A, LeMeur M, Segu L, Misslin R, Buhot MC, Hen R. Behavioral characterization of mice packing the 5-HT1B receptor. Nida Research Monograph. 161: 39-57. PMID 8784843 |
0.43 |
|
1996 |
Imbert G, Saudou F, Yvert G, Mandel J, Cancel G, Brice A. Dernière heure : Maladies neurodégénératives par expansion de polyglutamines : le sixième gène cloné (SCA2) MéDecine/Sciences. 12: 1463. DOI: 10.4267/10608/700 |
0.481 |
|
1995 |
Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agid Y, Hirsch EC, Mandel JL. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genetics. 10: 104-10. PMID 7647777 DOI: 10.1038/Ng0595-104 |
0.578 |
|
1995 |
Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 378: 403-6. PMID 7477379 DOI: 10.1038/378403A0 |
0.381 |
|
1994 |
Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L, Buhot MC, Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science (New York, N.Y.). 265: 1875-8. PMID 8091214 DOI: 10.1126/Science.8091214 |
0.523 |
|
1994 |
Saudou F, Hen R. 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochemistry International. 25: 503-32. PMID 7894328 DOI: 10.1016/0197-0186(94)90150-3 |
0.482 |
|
1994 |
Saudou F, Hen R. 5-Hydroxytryptamine receptor subtypes: molecular and functional diversity. Advances in Pharmacology (San Diego, Calif.). 30: 327-80. PMID 7833295 DOI: 10.1016/S1054-3589(08)60178-7 |
0.488 |
|
1992 |
Maroteaux L, Saudou F, Amlaiky N, Boschert U, Plassat JL, Hen R. Mouse 5HT1B serotonin receptor: cloning, functional expression, and localization in motor control centers. Proceedings of the National Academy of Sciences of the United States of America. 89: 3020-4. PMID 1557407 DOI: 10.1073/Pnas.89.7.3020 |
0.526 |
|
1992 |
Saudou F, Boschert U, Amlaiky N, Plassat JL, Hen R. A family of Drosophila serotonin receptors with distinct intracellular signalling properties and expression patterns. The Embo Journal. 11: 7-17. PMID 1310937 DOI: 10.1002/J.1460-2075.1992.Tb05021.X |
0.511 |
|
1990 |
Saudou F, Amlaiky N, Plassat JL, Borrelli E, Hen R. Cloning and characterization of a Drosophila tyramine receptor. The Embo Journal. 9: 3611-7. PMID 2170118 DOI: 10.1002/J.1460-2075.1990.Tb07572.X |
0.49 |
|
Show low-probability matches. |